Early Signs of Efficacy Study With Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis Patients
Clinical trial NCT02170025 · TERMINATED
Trial details
- NCT number
- NCT02170025
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-30
- Primary completion
- 2017-01-17
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.